Using the Naranjo scale, 33 cases (84.6%) were deemed to have a probable causal relationship between GLP-1 RAs and AP, while 4 cases (10.3%) were classified as possible
As GLP-1 use grows, HairSmart expects this to become one of the defining hair loss conversations of the next few years, not because the medications are doing something entirely new to the body, but because they're accelerating causes of hair loss that have existed all along, just rarely discussed in the open
Normally, you wouldnt be able to get versions of drugs like these this early in their lifecycle, as branded versions are typically all that's available until a drug companys patent expires
Join now Sign in Conditions Search conditions Treatments Symptoms About PatientsLikeMe Crisis Back to top User Done
Weight loss reduces inflammatory markers, which may further improve airway patency
It has been used for over 15 years to treat Type 2 diabetes